188 related articles for article (PubMed ID: 18087278)
1. Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer.
Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
Br J Cancer; 2008 Jan; 98(1):148-53. PubMed ID: 18087278
[TBL] [Abstract][Full Text] [Related]
2. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection.
Wang B; Xu D; Yu X; Ding T; Rao H; Zhan Y; Zheng L; Li L
Ann Surg Oncol; 2011 Sep; 18(9):2585-93. PubMed ID: 21347781
[TBL] [Abstract][Full Text] [Related]
3. Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer.
Hou J; Yu Z; Xiang R; Li C; Wang L; Chen S; Li Q; Chen M; Wang L
Exp Mol Pathol; 2014 Jun; 96(3):284-91. PubMed ID: 24657498
[TBL] [Abstract][Full Text] [Related]
4. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
5. Expression of Beclin-1, an autophagy-related protein, is associated with tumoral FOXP3 expression and Tregs in gastric adenocarcinoma: The function of Beclin-1 expression as a favorable prognostic factor in gastric adenocarcinoma.
Song MJ; Park S; Won KY
Pathol Res Pract; 2020 May; 216(5):152927. PubMed ID: 32204925
[TBL] [Abstract][Full Text] [Related]
6. The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer.
Kim HI; Kim H; Cho HW; Kim SY; Song KJ; Hyung WJ; Park CG; Kim CB
J Surg Oncol; 2011 Dec; 104(7):728-33. PubMed ID: 21792941
[TBL] [Abstract][Full Text] [Related]
7. Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer.
Maruyama T; Kono K; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Izawa S; Fujii H
Cancer Sci; 2010 Sep; 101(9):1947-54. PubMed ID: 20550524
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
9. Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia.
Haas M; Dimmler A; Hohenberger W; Grabenbauer GG; Niedobitek G; Distel LV
BMC Gastroenterol; 2009 Sep; 9():65. PubMed ID: 19732435
[TBL] [Abstract][Full Text] [Related]
10. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
[TBL] [Abstract][Full Text] [Related]
11. CCR7 expression and intratumoral FOXP3+ regulatory T cells are correlated with overall survival and lymph node metastasis in gastric cancer.
Zhou S; Shen Z; Wang Y; Ma H; Xu S; Qin J; Chen L; Tao H; Zhen Z; Chen G; Zhang Z; Li R; Xiao H; Zhong C; Yang Y; Liang C
PLoS One; 2013; 8(9):e74430. PubMed ID: 24040244
[TBL] [Abstract][Full Text] [Related]
12. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes.
Xia M; Zhao MQ; Wu K; Lin XY; Liu Y; Qin YJ
J Int Med Res; 2013 Aug; 41(4):1002-8. PubMed ID: 23760912
[TBL] [Abstract][Full Text] [Related]
13. High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment.
Ma GF; Miao Q; Liu YM; Gao H; Lian JJ; Wang YN; Zeng XQ; Luo TC; Ma LL; Shen ZB; Sun YH; Chen SY
Br J Cancer; 2014 Mar; 110(6):1552-60. PubMed ID: 24548868
[TBL] [Abstract][Full Text] [Related]
14. Higher densities of Foxp3
Yeong J; Thike AA; Lim JC; Lee B; Li H; Wong SC; Hue SS; Tan PH; Iqbal J
Breast Cancer Res Treat; 2017 May; 163(1):21-35. PubMed ID: 28233108
[TBL] [Abstract][Full Text] [Related]
15. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulatory Forkhead Box Protein p3-Positive Lymphocytes Are Associated with Overall Survival in Patients with Pancreatic Neuroendocrine Tumors.
de Reuver PR; Mehta S; Gill P; Andrici J; D'Urso L; Clarkson A; Mittal A; Hugh TJ; Samra JS; Gill AJ
J Am Coll Surg; 2016 Mar; 222(3):281-7. PubMed ID: 26809747
[TBL] [Abstract][Full Text] [Related]
17. The expression of C-MYC in gastric adenocarcinoma is associated with PD-L1 and FOXP3 expression: C-MYC overexpression is a good prognostic factor.
Won KY; Kim GY; Kim HK; Song MJ; Choi SI; Bae GE; Lim SJ
Pathol Res Pract; 2019 Nov; 215(11):152639. PubMed ID: 31582185
[TBL] [Abstract][Full Text] [Related]
18. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864
[TBL] [Abstract][Full Text] [Related]
19. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
[TBL] [Abstract][Full Text] [Related]
20. Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer.
Perrone G; Ruffini PA; Catalano V; Spino C; Santini D; Muretto P; Spoto C; Zingaretti C; Sisti V; Alessandroni P; Giordani P; Cicetti A; D'Emidio S; Morini S; Ruzzo A; Magnani M; Tonini G; Rabitti C; Graziano F
Eur J Cancer; 2008 Sep; 44(13):1875-82. PubMed ID: 18617393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
